Citation: A. Thiele et al., RETROPERITONEAL FIBROSIS AND ARTHRITIS - MANIFESTATION OF THE SAME DISEASE, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 285-291
Citation: H. Fenner, IMMUNOPHARMACOLOGICAL PROFILE AND THERAPEUTIC PERSPECTIVES OF ANTI-TNF-ALPHA-THERAPIES, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 294-297
Citation: B. Manger, EXPERIMENTAL-THERAPY OF RHEUMATOID-ARTHRITIS USING ANTIBODIES AGAINSTTUMOR-NECROSIS-FACTOR, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 298-301
Citation: Lba. Vandeputte et al., TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH A TUMOR-NECROSIS-FACTOR-ALPHA RECEPTOR FUSION PROTEIN (TNFR55-IGG1) - RESULTS FROM DOUBLE-BLIND PLACEBO-CONTROLLED 3-MONTH TRIALS, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 302-306
Citation: O. Sander et R. Rau, TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH A TUMOR-NECROSIS-FACTOR-ALPHA RECEPTOR FUSION PROTEIN (TNFR55-IGG1) - A MONOCENTRIC OBSERVATION IN 80 PATIENTS, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 307-311
Citation: R. Rau et al., TREATMENT OF RHEUMATOID-ARTHRITIS WITH A HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 312-319
Citation: G. Keysser et al., ANTI-CD4-TREATMENT OF RHEUMATOID-ARTHRITIS - IS THE BATTLE ALREADY LOST, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 320-325
Citation: V. Strand, FUTURE-DEVELOPMENT IN THE TREATMENT OF CHRONIC ARTHRITIS WITH BIOLOGICAL SUBSTANCES, ALONE OR IN COMBINATION, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 326-327
Citation: E. Luithlen et E. Aufderheide, FROM PART I - FOUNDATIONS - ASPECTS OF HEALTH-CARE POLICY IN QUALITY ASSURANCE, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 330-331
Citation: J. Ruof et O. Schoffski, COSTS AND OUTCOMES - LIMITATIONS BETWEEN OPTIMIZING AND RATIONING OF HEALTH-CARE, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 340-344
Citation: B. Sens, BAK KBV/AWMF-CURRICULUM QUALITY MANAGEMENT FOR PHYSICIANS - CONCEPT OF A PURPOSEFUL TRAINING-PROGRAM/, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 351-354
Citation: W. Keitel, QUALITY RECOMMENDATIONS OF THE GERMAN SOCIETY OF RHEUMATOLOGY - BASISFOR FURTHER INTENTIONS, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 355-357
Authors:
LEMMEL EM
GROMNICAIHLE E
KRIEGEL W
SCHMIDT KL
Citation: Em. Lemmel et al., POSITION OF THE DEUTSCHE-GESELLESCHAFT-FUR-RHEUMATOLOGIE WITH REGARD TO THE USE OF THYMUS PREPARATIONS IN RHEUMATIC DISEASES, Zeitschrift fur Rheumatologie, 57(5), 1998, pp. 360-362
Authors:
WITTENBORG A
PETERSEN G
LORKOWSKI G
BRABANT T
Citation: A. Wittenborg et al., EFFICACY OF VITAMIN-E VERSUS DICLOFENAC-SODIUM IN THE TREATMENT OF PATIENTS WITH CHRONIC RHEUMATOID-ARTHRITIS, Zeitschrift fur Rheumatologie, 57(4), 1998, pp. 215-221
Authors:
JUSTEN HP
MULLERLADNER U
LEEB I
LANG B
WESSINGHAGE D
Citation: Hp. Justen et al., THERAPY OF BILATERAL AVASCULAR NECROSIS OF THE FEMORAL CONDYLES BY SYNOVECTOMY, ARTHROLYSIS, AND ARTHROPLASTY IN ANTIPHOSPHOLIPID-ANTIBODY SYNDROME (APL), Zeitschrift fur Rheumatologie, 57(4), 1998, pp. 222-226
Citation: C. Binder et al., SEVERE DIGITAL GANGRENE AS AN EARLY MANIFESTATION OF WEGENERS GRANULOMATOSIS IN A YOUNG FEMALE, Zeitschrift fur Rheumatologie, 57(4), 1998, pp. 227-230
Citation: A. Zink, RESEARCH-PROGRAM ON THE EPIDEMIOLOGY OF RHEUMATIC DISEASES OF THE GERMAN MINISTRY FOR EDUCATION, SCIENCE, RESEARCH AND TECHNOLOGY - REPORT ON THE LAST 9 YEARS, Zeitschrift fur Rheumatologie, 57(4), 1998, pp. 232-233
Citation: D. Schmidt et B. Haussler, ASSESSMENT OF THE CARE OF PATIENTS WITH RHEUMATIC DISEASE USING ROUTINE DATA FROM HEALTH-INSURANCE AGENCIES, Zeitschrift fur Rheumatologie, 57(4), 1998, pp. 234-237